Lifecore Biomedical, trading on the NASDAQ:LFCR, is gearing up for its quarterly earnings release on Friday, October 3, 2025. The company, a key player in the biomedical sector, is under the spotlight as it prepares to unveil its financial performance for the quarter ending August 2025. With Wall Street setting its eyes on an earnings per share (EPS) of -$0.30 and projected revenue of approximately$26.3 million, the stakes are high for LFCR.Despite the anticipated quarterly loss, Lifecore Biomedical is exp ...